实时全球研报
Still healthy growth in the absolute but losing narrative control: Visibility into next year‘s growth drivers remains limited, with weaker second derivatives likely to dominate the narrative over the coming quarters.
研报英文原文证据摘录
Still healthy growth in the absolute but losing narrative control: Visibility into next year‘s growth drivers remains limited, with weaker second derivatives likely to dominate the narrative over the coming quarters.
Equity Research
U.S. Media
17 July 2026
Netflix, Inc.
Still healthy growth in the
absolute but losing narrative
NFLX EQUAL WEIGHTcontrol
Unchanged
Visibility into next year's growth drivers remains limited, with U.S. Media NEUTRAL
weaker second derivatives likely to dominate the narrative Unchanged
over the coming quarters. Price Target lowered -6% fromUSDUSD80.0085.00
Price (16-Jul-26) USD 74.35
Netflix results and guide were roughly in line with prior guide and expectations (Figure 1-3) but Potential Upside/Downside +7.6%
given recent engagement concerns, risk/reward in the name is asymmetric as we had Source: Bloomberg, Barclays Research
highlighted earlier this week (please see 2Q26 Media Preview: M&A everywhere, conviction
nowhere, 14 July 2026). As suggested in the referenced report, we think the market was set to Market Cap (USD mn) 313072
punish small second derivative misses by a lot more than it is willing to reward small beats. In Shares Outstanding (mn) 4210.80
that spirit, the company’s lack of guidance increase for the year, guidance of a slight sequential Free Float (%) 99.41
decline in ex FX revenue growth in Q3 and continuing weakness in engagement resulted in a 52 Wk Avg Daily Volume (mn) 41.7
disproportionate post close move in the stock vs what results should have warranted. Dividend Yield (%) N/A
• The company took a price increase in late Q1 which was expected to benefit Q2 and while Return on Equity TTM (%) 48.50
revenue growth did see a tailwind from this, it was a bit less than anticipated (FX neutral) as Current BVPS (USD) 7.39
本摘录由系统从所标注的 PDF 证据页直接提取并保留英文原文,不做批量翻译;登录后在阅读器切换中文时才按需翻译。
打开研报阅读器